Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ARTLthis companyArtelo Biosciences, Inc.	$2.00	-0.22×	-2.26×	0×	-0.24×	-565.9%	0.0%	0.0%	0.0%	1012.5%	1919.9%	-296.4%	-0.53×	-0.01×	-58.78×	0.17×	0.0%	2	-17.34	2	C+
GTBPGT Biopharma, Inc.	$4.39	-0.13×	0.75×	0×	0.09×	441.2%	0.0%	0.0%	0.0%	-490.0%	-214.7%	-298.3%	0×	0.24×	-97.81×	3.5×	5.3%	1	-185.96	2	C
REVBRevelation Biosciences, Inc.	$4.00	-0.13×	0.22×	0×	0.88×	2518.1%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	2	-7.62	2	B-
Peer median	—	-0.13×	0.49×	0×	0.48×	1479.7%	0.0%	0.0%	0.0%	-295.3%	-154.5%	-357.3%	0.04×	0.67×	-48.91×	4.45×	2.6%	2	-96.79	2	—